Clinical Trials on Atherosclerotic Cardiovascular Disease (ASCVD) in Belgium

Total 1867 results

Eli Lilly and Company

Recruiting

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Elevated Lp(a) | Atherosclerotic Cardiovascular Disease (ASCVD)

United States, Australia, Spain, Canada, Argentina, China, Italy, France, Japan, Taiwan, Korea, Republic of, Denmark, Germany, Hungary, Israel, Austria, Belgium, Netherlands, Brazil, Mexico, Romania, United Kingdom, Greece, Czechia, Poland and more
Novartis Pharmaceuticals

Recruiting

The Belgian REAL (BE.REAL) Registry (BE REAL)

Atherosclerotic Cardiovascular Disease

Belgium
Novo Nordisk A/S

Completed

A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease

Atherosclerotic Cardiovascular Disease

Germany, Poland, United States, Netherlands, Japan, Greece, Belgium
Amgen

Active, not recruiting

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial

Atherosclerotic Cardiovascular Disease

United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Italy, Portugal, Greece, Hong Kong, Hungary, United Kingdom, France, Bulgaria, Germany, Finland, Japan, Sweden, Canada, Denmark, Icelan... and more
Amgen

Completed

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Atherosclerotic Cardiovascular Disease

Canada, United States, Belgium, Spain, China, Korea, Republic of, Australia, Netherlands, Austria, Czechia, Taiwan, Hungary, Italy, Portugal, United Kingdom, Greece, Hong Kong, Turkey, France, Bulgaria, Germany, Finland, Japan, Sweden, ... and more
Novartis Pharmaceuticals

Recruiting

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Primary Prevention of Atherosclerotic Cardiovascular Disease

United States, China, Italy, Spain, France, Netherlands, Poland, Switzerland, Taiwan, Greece, Thailand, Brazil, India, Hungary, Latvia, Mexico, Israel, Malaysia, Turkey, Argentina, Singapore, Australia, Belgium, Bulgaria, Denmark, Croatia, South... and more
Novartis Pharmaceuticals

Active, not recruiting

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease (VICTORION-2P)

Atherosclerotic Cardiovascular Disease

United States, China, South Africa, Spain, Austria, Belgium, Croatia, Estonia, Hungary, Taiwan, Turkey, Netherlands, Italy, Australia, Czechia, Denmark, France, Israel, Korea, Republic of, Thailand, Argentina, Bulgaria, Greece, Romania, Sloveni... and more
AstraZeneca
The Cleveland Clinic; IQVIA RDS Inc.

Completed

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia (STRENGTH)

Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

United States, Belgium, Italy, Netherlands, Denmark, Taiwan, Poland, Russian Federation, Korea, Republic of, Hungary, United Kingdom, China, New Zealand, Czechia, Australia, South Africa, Ukraine, Japan, Canada, Mexico, Lithuania, Estoni...
University Hospital, Antwerp

Completed

Blood Endothelium Progenitor Cells and Dendritic Cells as Predictive Biomarkers of In-stent Restenosis

Atherosclerosis | Restenosis

Belgium
KU Leuven

Completed

Exercise Therapy in Patients With Peripheral Artery Disease: Evaluating the Clinical Effectiveness of Exercise Therapy and Exploring Determinants of Improvement (PROSECO)

Peripheral Arterial Disease

Belgium
be Medical

Completed

Remedy, Biodegradable Peripheral Stent Registry

Peripheral Arterial Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Biomechanical Analysis of Arterial Tissue From Patient Suffering From Peripheral Artery Disease in the Lower Limb

Peripheral Arterial Disease

Belgium
ID3 Medical
CyndRx, LLC

Completed

AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial

Peripheral Arterial Disease

Belgium
Spectranetics Corporation

Completed

ModificatiOn and Treatment of stenoseD Calcified inFrainguinal Lesions With Laser atherectomY in a Pilot Study (MODIFY)

Peripheral Arterial Disease

Belgium
be Medical

Completed

Endovascular Treatment of Atherosclerotic Lesions in the SFA Using the Sinus-superflex-635 Stent

Atherosclerotic Heart Disease

Belgium
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Completed

Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events (SANTORINI)

Cardiovascular Diseases | Dyslipidemia | Hypercholesterolemia | Atherosclerotic Cardiovascular Disease

Finland, Netherlands, Spain, Belgium, Sweden, Austria, United Kingdom, Switzerland, Denmark, France, Germany, Portugal, Italy, Ireland
Sanofi
Regeneron Pharmaceuticals

Completed

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

Atherosclerotic Cardiovascular Disease

China, Hong Kong, Austria, Bulgaria, Norway, Peru, France, Japan, Spain, Lithuania, Philippines, Israel, Belgium, Croatia, Poland, Hungary, Chile, Mexico, Latvia, Singapore, Switzerland, Colombia, Greece, Ukraine, Turkey, Finland, United States and more
University Hospital, Ghent
JOTEC Company

Completed

Multicentric, Prospective, Randomized, Comparing Trial Between Bypass of the Femoropoplitea by PTFE and Heparin Bounded PTFE

Peripheral Vascular Diseases

Belgium
ID3 Medical
CyndRx, LLC

Terminated

The AbsorbaSeal Vascular Closure Device Trial

Peripheral Arterial Disease

Belgium
Philips Clinical & Medical Affairs Global

Completed

Tack Optimized Balloon Angioplasty (TOBA) Study (TOBA)

Peripheral Vascular Disease

Belgium
Flanders Medical Research Program

Completed

BeSmooth Study, Investigating the BeSmooth Peripheral Stent System for the Treatment of Iliac Lesions (BeSmooth)

Peripheral Arterial Disease

Belgium
Flanders Medical Research Program

Completed

NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions

Peripheral Arterial Disease

Belgium
be Medical

Unknown

Safety and Performance of the Zeus CC Stent for the Treatment of Iliac Occlusive Disease (EAZY)

Peripheral Artery Disease

Belgium
KU Leuven
Hasselt University; Jessa Hospital

Completed

Telerehabilitation in Coronary Heart Disease (TRiCH)

Myocardial Infarction | Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) | Percutaneous Transluminal Cutting Balloon Angioplasty of Popliteal Vein Using Fluoroscopic Guidance

Belgium
ID3 Medical

Completed

Belgian Trial Evaluating the ClearLumen II Peripheral Thrombectomy System Recanalization of (Sub)Acute Thrombotic Femoropopliteal Occlusions (BELTHROM)

Peripheral Arterial Disease

Belgium
Sensome

Recruiting

Impedance Sensor Evaluated in Peripheral Artery Disease for Tissue Detection (SEPARATE)

Peripheral Vascular Disease

Belgium
Medtronic Endovascular
MEDRAD, Inc.

Completed

Atherectomy Followed by a Drug Coated Balloon to Treat Peripheral Arterial Disease (DEFINITIVE AR)

Peripheral Arterial Disease | Claudication

Belgium
University Hospital, Ghent

Completed

Belgian Prospective Multicentre Registry on the Performance of the Smart Stent in the Superficial Femoral Artery According to the New Tasc II-classification

Peripheral Vascular Disease

Belgium
be Medical
Universitaire Ziekenhuizen KU Leuven; Ziekenhuis Oost-Limburg

Completed

Belgian Prospective Multicentre Registry to Evaluate Safety and Performance of the Optimed Stent in the Superficial Femoral Artery (BOSS)

Peripheral Arterial Disease

Belgium
KU Leuven

Completed

Observational Feasibility Study of Home-based Training With Therabands in PAD-patients

Intermittent Claudication | Peripheral Artery Disease

Belgium
Universitaire Ziekenhuizen KU Leuven
University Hospital, Ghent; Universitair Ziekenhuis Brussel; Imelda Hospital,... and other collaborators

Recruiting

ShOckwave ballooN or Atherectomy With Rotablation in Calcified Coronary Artery Lesions, the SONAR Trial (SONAR)

Coronary Artery Disease | Calcified Atheroma

Belgium
Flanders Medical Research Program
Medtronic Neurovascular Clinical Affairs

Completed

DURABILITY+ : a Prospective, Multi-center, Controlled Study With the Everflex+ Stent in SFA Lesions (DURABILITY+)

Peripheral Arterial Disease

Belgium
Flanders Medical Research Program

Completed

Physician-Initiated Trial Investigating the BeGraft Peripheral Stent Graft System

Peripheral Vascular Disease

Belgium
Erasme University Hospital
Fonds National de la Recherche Scientifique; Fonds Erasme

Completed

Uric Acid Effects on Endothelium and Oxydative Stress

Hypertension | Oxidative Stress | Cardiovascular System | Endothelial Function

Belgium
Contego Medical, Inc.

Completed

Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System (ENTRAP)

Peripheral Arterial Disease | Intermittent Claudication | Atherosclerosis of Femoral Artery

Belgium, Germany
Flanders Medical Research Program

Unknown

REFLOW Study, Investigating the Efficacy of the LEGFLOW DCB in TASC C&D Fempop Lesions

Peripheral Arterial Disease

Belgium
Duomed

Completed

Endovascular Treatment of Peripheral Artery Disease (PAD)

Peripheral Arterial Disease | Iliac Artery Disease | Femoropopliteal Occlusive Disease | Below-the-knee Obstruction

Belgium
be Medical

Terminated

Endovascular Treatment of Peripheral Artery Disease (PAD)

Peripheral Arterial Disease | Iliac Artery Disease | Femoropopliteal Occlusive Disease | Below-the-knee Obstruction

Belgium
QualiMed Innovative Medizinprodukte GmbH

Not yet recruiting

Safety and Efficacy of the QBX Peripheral Balloon Expandable Stent System in Peripheral Artery Disease (PAD) (QBX-RADAR)

Peripheral Arterial Disease

Belgium
ID3 Medical

Active, not recruiting

Belgian Trial Investigating the LifeStream Stent in Complex TASC C and D Iliac Lesions (BELSTREAM)

Peripheral Arterial Disease

Belgium
Silk Road Medical
Technical University of Munich; University Ghent; Complejo Hospitalario Toledo

Completed

The ENROUTE Transcarotid Neuroprotection System (ENROUTE Transcarotid NPS) DW-MRI Study (DW-MRI OUS)

Carotid Artery Plaque | Carotid Stenosis | Carotid Artery Diseases | Carotid Atherosclerosis

Belgium, Spain, Germany
Flanders Medical Research Program

Completed

Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlusion (ROBINSON)

Peripheral Vascular Disease

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Arterial Stiffness and Calcifications in Incident Renal Transplant Recipients (ASCIT)

Atherosclerosis | Renal Transplant | Arterial Stiffness

Belgium
Flanders Medical Research Program

Unknown

The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery for the Treatment The Cook Zilver PTX Drug-eluting Stent Versus Bypass Surgery of Femoropopliteal TASC C&D Lesions (ZILVERPASS)

Peripheral Vascular Disease

Belgium
C. R. Bard

Completed

LEVANT I, The Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis (LEVANT I)

Arteriosclerosis | Atherosclerosis | Vascular Disease

Germany, Belgium
Boston Scientific Corporation

Completed

Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project (MAJESTIC)

Atherosclerosis of Native Arteries of the Extremities

New Zealand, Germany, Belgium, Australia, Austria
Provascular GmbH
William Cook Europe

Completed

Evaluation of Paclitaxel Eluting Stent vs Paclitaxel Eluting Balloon Treating Peripheral Artery Disease of the Femoral Artery

Peripheral Artery Disease

Belgium, Germany
Flanders Medical Research Program

Unknown

In.Pact Flexion, Investigating the Performance of the In.Pact Admiral DEB for Popliteal Lesions (INPCTFLEXION)

Peripheral Arterial Disease

Belgium
Flanders Medical Research Program

Completed

Physician-Initiated Trial Investigating the Efficacy of Endovascular Treatment of Femoropopliteal Arterial Stenotic Disease With the Biotronik Passeo-18 Lux Drug Releasing Balloon and the Biotronik Pulsar-18 Stent (Comparing With 4EVER Trial Results) (BIOLUX 4EVER)

Peripheral Vascular Disease

Belgium
Cardionovum GmbH
Archer Research

Completed

Study Comparing Legflow Versus Bare Balloon Angioplasty for Treatment of Atherosclerotic Disease

Atherosclerosis

Belgium, Germany, France

3

Subscribe